Old Web
English
Sign In
Acemap
>
authorDetail
>
Kai‐Hsin Liao
Kai‐Hsin Liao
Pfizer
Anesthesia
Pharmacodynamics
Medicine
Kexin
PCSK9
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Mechanism‐Based Pharmacokinetic/Pharmacodynamic Model for Bococizumab, a Humanized Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, and Its Application in Early Clinical Development
2017
The Journal of Clinical Pharmacology
Chandrasekhar Udata
Pamela D. Garzone
Barry Gumbiner
Tenshang Joh
Hong Liang
Kai‐Hsin Liao
Jason H. Williams
Xu Meng
Show All
Source
Cite
Save
Citations (4)
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF‐05280586, a proposed rituximab biosimilar, and rituximab
2016
British Journal of Clinical Pharmacology
Jason H. Williams
Matthew M. Hutmacher
Matthew L. Zierhut
Jean‐Claude Becker
Barry Gumbiner
George Spencer‐Green
L.A. Melia
Kai‐Hsin Liao
Matthew Suster
Donghua Yin
Ruifeng Li
Xu Meng
Show All
Source
Cite
Save
Citations (12)
1